{
  "paper_metadata": {
    "pmid": "23470493",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the KCNH2 gene variant c.G1681A, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.G1681A",
      "protein_notation": "p.Ala561Thr",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3,
        "demographics": "Patient (proband), father (genetically normal), mother (asymptomatic carrier)",
        "phenotype": "Long-QT syndrome type 2 (LQT2)"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 1,
        "unaffected_count": 1,
        "uncertain_count": 1,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Proband",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "Long-QT syndrome type 2",
          "evidence_sentence": "Differentiation of hiPSCs produced beating clusters within 8\u201316 days, which contained cardiomyocytes as evidenced by characteristic cardiac muscle striations."
        },
        {
          "individual_id": "Mother",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "Asymptomatic carrier of the same mutation",
          "evidence_sentence": "The patient's mother (asymptomatic carrier of same mutation, not under \u03b2-blocker treatment)."
        },
        {
          "individual_id": "Father",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "Genetically normal",
          "evidence_sentence": "The patient's father (genetically normal)."
        }
      ],
      "functional_data": {
        "summary": "The c.G1681A mutation in KCNH2 leads to impaired glycosylation and channel transport, resulting in prolonged action potential durations and increased susceptibility to arrhythmias.",
        "assays": [
          "Electrophysiological analysis",
          "Whole-cell patch-clamp",
          "Multi-electrode array analysis"
        ]
      },
      "segregation_data": "The mutation segregates with disease in the family, with the mother being an asymptomatic carrier.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the potential for allele-specific RNA interference as a therapeutic approach.",
      "key_quotes": [
        "Allele-specific RNA interference directed towards the mutated KCNH2 mRNA caused knockdown, while leaving the wild-type mRNA unaffected.",
        "Over 500 hERG mutations are identified, which primarily show autosomal-dominant-negative inheritance."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the KCNH2 variant was extracted thoroughly."
  }
}